Skip to content

A Registry Study on Serumal Biomarkers About Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.

A Chinese Registry to Determine the Serumal Biomarkers for Prognosis of Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04107571
Acronym
ASBA-CABG
Enrollment
2000
Registered
2019-09-27
Start date
2019-01-01
Completion date
2024-06-30
Last updated
2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Keywords

Coronary artery bypass graft, Biomarker, Prognosis

Brief summary

This is a national registry study to determine the serumal biomarkers for prognosis of adverse events in patients undergoing coronary artery bypass grafting.

Interventions

PROCEDUREA type of operation for coranary heart disease patients.

A type of operation for coranary heart disease patients.

Sponsors

Beijing Institute of Heart, Lung and Blood Vessel Diseases
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Subject undergoing coronary artery bypass grafting; 2. Age is more than 18 and less than 80 years old; 3. Male and non pregnancy female; 4. Subject who understands study requirements and agrees to sign an informed consent from prior to study procedures.

Exclusion criteria

1. Pregnancy female; 2. Participate in other clinical trial in the last 1 month. 3. Subject who doesn't agree to sign an informed consent from prior to study procedures. 4. Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.

Design outcomes

Primary

MeasureTime frame
All-cause death and cardiac deathThese data is collected during follow-up visit at in-hospital/1 year after discharge

Secondary

MeasureTime frameDescription
Major adverse cardiac events (MACE)These data is collected during follow-up visit at in-hospital/1 year after dischargeA composite of death, myocardial infarction, stroke, heart failure, ventricular arrhythmia

Countries

China

Contacts

Primary ContactYulin Li, PHD
lyllyl_1111@163.com86-010-64426153
Backup ContactJie Du, PHD
jiedubj@126.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026